Journal
PHARMACEUTICAL CHEMISTRY JOURNAL
Volume 50, Issue 3, Pages 195-199Publisher
SPRINGER
DOI: 10.1007/s11094-016-1422-1
Keywords
antituberculosis drug; cycloserine; HPLC/MS; validation; pharmacokinetics; bioequivalence
Categories
Ask authors/readers for more resources
A selective and specific quantitative assay with HPLC/MS determination of the broad-spectrum antituberculosis antibiotic cycloserine in blood plasma with reserpine internal standard was developed and validated. It was shown that the method was accurate and precise and linear in the range 0.5 - 20.0 mu g/mL. A calibration curve obeyed the equation Y = aX + b, where a = 0.0893 and b = -0.0134 with a correlation coefficient of 0.9994. The cycloserine limit of detection was 0.1 mu g/mL; the limit of quantitation, 0.5 mu g/mL. The recoveries of cycloserine from the matrix at low (0.5 mu g/mL) and high (20.0 mu g/mL) drug concentrations were 41.7 and 62.4%, respectively, with matrix factors of 0.28 and 0.34, respectively, normalized to the internal standard.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available